Inter- and Intrareader Agreement of NI-RADS in the Interpretation of Surveillance Contrast-Enhanced CT after Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

NI-RADS在口腔和口咽鳞状细胞癌治疗后监测性增强CT解读中的阅片者间和阅片者内一致性

阅读:1

Abstract

BACKGROUND AND PURPOSE: The Neck Imaging Reporting and Data System was introduced to assess the probability of recurrence in surveillance imaging after treatment of head and neck cancer. This study investigated inter- and intrareader agreement in interpreting contrast-enhanced CT after treatment of oral cavity and oropharyngeal squamous cell carcinoma. MATERIALS AND METHODS: This retrospective study analyzed CT datasets of 101 patients. Four radiologists provided the Neck Imaging Reporting and Data System reports for the primary site and neck (cervical lymph nodes). The Kendall's coefficient of concordance (W), Fleiss κ (κ(F)), the Kendall's rank correlation coefficient (τ(B)), and weighted κ statistics (κ(w)) were calculated to assess inter- and intrareader agreement. RESULTS: Overall, interreader agreement was strong or moderate for both the primary site (W = 0.74, κ(F) = 0.48) and the neck (W = 0.80, κ(F) = 0.50), depending on the statistics applied. Interreader agreement was higher in patients with proved recurrence at the primary site (W = 0.96 versus 0.56, κ(F) = 0.65 versus 0.30) or in the neck (W = 0.78 versus 0.56, κ(F) = 0.41 versus 0.29). Intrareader agreement was moderate to strong or almost perfect at the primary site (range τ(B) = 0.67-0.82, κ(w) = 0.85-0.96) and strong or almost perfect in the neck (range τ(B) = 0.76-0.86, κ(w) = 0.89-0.95). CONCLUSIONS: The Neck Imaging Reporting and Data System used for surveillance contrast-enhanced CT after treatment of oral cavity and oropharyngeal squamous cell carcinoma provides acceptable score reproducibility with limitations in patients with posttherapeutic changes but no cancer recurrence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。